FDA panel calls for clarity on duration of bone drug use, but sets no cutoff
12 September 2011
Donna Young
Please Login to read the full article.
12 September 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Will PDUFA V be a 'damned if it does, damned if it doesn't' scenario for FDA?
- US FDA warns of potential esophageal cancer link with oral bisphosphonate use
- Ibandronate set for filing in Japan following positive local trial
- Denosumab filed for large but competitive osteoporosis indication in Japan
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
